Extend Fertility Company Profile

Background

Extend Fertility, established in 2016, is a pioneering fertility services provider based in New York City. The company was founded with the mission to democratize egg freezing, aiming to make fertility preservation more accessible and affordable. By offering egg freezing services at 40% below the national average cost, Extend Fertility quickly became the largest egg freezing practice in the United States by 2017. Over time, the company expanded its services to include a comprehensive range of infertility treatments, such as in vitro fertilization (IVF) and intrauterine insemination (IUI), all delivered in a personalized, high-quality, and data-driven environment.

Key Strategic Focus

Extend Fertility's strategic focus centers on:

Comprehensive Fertility Services: Offering a full spectrum of fertility treatments, including egg freezing, IVF, IUI, embryo freezing, and preimplantation genetic testing.

Affordability and Accessibility: Providing services priced 20–40% lower than the national average to make fertility care more accessible.

Personalized, Data-Driven Care: Utilizing a truth-based approach to deliver individualized treatment plans based on cutting-edge science and patient data.

Expansion and Growth: Leveraging strategic investments to expand into new business lines and geographic markets.

Financials and Funding

In February 2019, Extend Fertility secured a $15 million Series A investment from Regal Healthcare Capital Partners. This funding was intended to support the company's expansion into new business lines and geographic markets. At that time, the company employed approximately 60 people.

Technological Platform and Innovation

Extend Fertility distinguishes itself through:

State-of-the-Art Laboratory: A lab designed and built in 2016 to deliver optimal results, featuring individual temperature-controlled benchtop incubators for precise control and stability of temperature and pH levels.

Experienced Embryology Team: Led by highly experienced embryologists utilizing vitrification or "flash freezing" techniques for all egg and embryo freezing, achieving superior thaw rates—90% for eggs and nearly 100% for embryos.

Leadership Team

Joshua U. Klein, MD, FACOG: Co-founder and Chief Clinical Officer, Dr. Klein is a board-certified reproductive endocrinologist with extensive experience in fertility treatments.

Nataki Douglas, MD, PhD: Chief Scientific Officer, Dr. Douglas is board-certified in obstetrics and gynecology and reproductive endocrinology and infertility, with a focus on understanding uterine requirements for successful embryo implantation and pregnancy.

Anne Hogarty: Appointed CEO in February 2019, Ms. Hogarty previously served as Chief Business Officer at Prelude Fertility and President of MyEggBank.

Leadership Changes

In February 2019, Anne Hogarty was appointed CEO, succeeding Ilaina Edison, who remained on the board of directors and continued as an adviser.

Competitor Profile

Market Insights and Dynamics

The fertility industry has become a lucrative sector for private equity investors, characterized by a fragmented landscape with resilient income and healthy growth. The increasing trend of starting families later has boosted the demand for IVF services, with 2.5% of US births assisted by fertility treatments.

Competitor Analysis

Kindbody: A fertility clinic network offering a range of services, including egg freezing and IVF, with a focus on accessibility and patient experience.

Prelude Fertility: A network of fertility clinics providing services such as IVF, egg donation, and egg freezing, aiming to offer comprehensive fertility care.

CCRM Fertility: A fertility treatment center specializing in advanced fertility treatments, including IVF and egg freezing, with a focus on personalized care.

Strategic Collaborations and Partnerships

In February 2019, Extend Fertility announced a $15 million Series A investment by Regal Healthcare Capital Partners to support the company's expansion into new business lines and geographic markets.

Operational Insights

Extend Fertility's strategic considerations include:

Market Position: As a leading provider of egg freezing services, the company leverages its expertise to offer comprehensive fertility treatments.

Competitive Advantages: The combination of affordability, personalized care, and a data-driven approach differentiates Extend Fertility in the market.